Drug Discovery

Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

How fluid flow through the body can affect the ways in which antibiotics work.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Purdue University’s Young Institute is tackling pharma’s toughest challenges— from mRNA stability to aseptic manufacturing.

We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.

How antisense oligonucleotides open up targeted approaches to rare disease treatment.

Researchers develop a new platform to improve delivery of oligonucleotide therapies to muscle.